August 26, 2016 5:07 AM ET

Biotechnology

Company Overview of Icagen, Inc. Prior to Merger with XRpro Sciences, Inc.

Company Overview

Icagen, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of orally-administered small molecule drugs that modulate ion channel targets. Its drug candidates include ICA-105665, a small molecule compound that targets specific KCNQ ion channels for the treatment of epilepsy and pain, which is in Phase II clinical trial stage; and a compound that targets the sodium channel Nav1.7 for the treatment of pain, which is in Phase I clinical trial stage. The company also engages in conducting research and development activities in various disease areas, including epilepsy, pain, and inflammation. It has a collaborative research and license agreement with P...

4222 Emperor Boulevard

Suite 350

Durham, NC 27703

United States

Founded in 1992

38 Employees

Phone:

919-941-5206

Fax:

919-941-0813

Key Executives for Icagen, Inc. Prior to Merger with XRpro Sciences, Inc.

Co-founder, Chief Executive Officer and President
Age: 67
Vice President and Treasurer
Age: 56
Vice President, Secretary and Director
Controller and Senior Director of Finance
Age: 61
Vice President of New Product Development
Age: 58
Compensation as of Fiscal Year 2016.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Icagen, Inc. Prior to Merger with XRpro Sciences, Inc., please visit www.icagen.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.